Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Avadel Pharmaceuticals PLC. (AVDL : NSDQ)

• Company Description    Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France. Number of Employees: 188

• Price / Volume Information    Yesterday's Closing Price: $15.86 Daily Weekly Monthly 20 Day Moving Average: 1,389,380 shares Shares Outstanding: 97.10 (millions) Market Capitalization: $1,539.97 (millions) Beta: 1.58 52 Week High: $16.66 52 Week Low: $6.38 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 17.48% 15.36% 12 Week 70.17% 54.50% Year To Date 50.90% 34.74%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 10 EARLSFORT TERRACE - DUBLIN,L2 D02 T380 IRL ph: 353-1901-5201 fax: 353-1526-1077 investors@avadel.com http://www.avadel.com

• General Corporate Information    Officers Gregory J. Divis - Director; Chief Executive Officer and Principal Ex Geoffrey M. Glass - Non-Executive Chairman of the Board and Director Thomas S. McHugh - Chief Financial Officer and Principal Financial an Naseem S. Amin - Director Eric J. Ende - Director Peer Information Avadel Pharmaceuticals PLC. (GSAC) Avadel Pharmaceuticals PLC. (CASI) Avadel Pharmaceuticals PLC. (ALCD.) Avadel Pharmaceuticals PLC. (OMNN) Avadel Pharmaceuticals PLC. (CGPI.) Avadel Pharmaceuticals PLC. (CATX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-DRUGS Sector: Medical CUSIP: G29687103 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/11/25 Share - Related Items Shares Outstanding: 97.10 Most Recent Split Date: (:1) Beta: 1.58 Market Capitalization: $1,539.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.07 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.25 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/11/25

• Fundamental Ratios P/E Current FY Estimate: 64.42 Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 16.92 Price/Cash Flow: - Price / Sales: 6.97 EPS Growth vs. Year Ago Period: 171.43% vs. Previous Quarter: 300.00% Sales Growth vs. Year Ago Period: 64.15% vs. Previous Quarter: 29.74% ROE 06/30/25 - -3.73 03/31/25 - -36.07 12/31/24 - -65.73 ROA 06/30/25 - -1.73 03/31/25 - -16.30 12/31/24 - -30.15 Current Ratio 06/30/25 - 2.79 03/31/25 - 2.73 12/31/24 - 2.75 Quick Ratio 06/30/25 - 2.38 03/31/25 - 2.33 12/31/24 - 2.33 Operating Margin 06/30/25 - -1.32 03/31/25 - -13.58 12/31/24 - -28.88 Net Margin 06/30/25 - -1.32 03/31/25 - -13.58 12/31/24 - -28.88 Pre-Tax Margin 06/30/25 - -2.64 03/31/25 - -13.72 12/31/24 - -29.02 Book Value 06/30/25 - 0.94 03/31/25 - 0.77 12/31/24 - 0.77 Inventory Turnover 06/30/25 - 1.14 03/31/25 - 1.10 12/31/24 - 0.99 Debt-to-Equity 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Debt-to-Capital 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00

Powered by Zacks Investment Research ©